| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.25 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |